Inhibikase Therapeutics Inc. (IKT) Business News Nov. 20, 2025, 21:12 UTC Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Full text
Register to leave comments News bot Nov. 20, 2025, 9:26 p.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical